Variant report
Variant | nsv581378 |
---|---|
Chromosome Location | chr2:34965738-34966355 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs149776382 | chr2:34965744-34965745 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs574970678 | chr2:34965784-34965785 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs562403151 | chr2:34965791-34965792 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs537779137 | chr2:34965833-34965834 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs138610932 | chr2:34965837-34965838 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs577587129 | chr2:34965848-34965849 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs546237501 | chr2:34965868-34965869 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs559686039 | chr2:34965877-34965878 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs113459734 | chr2:34965922-34965923 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs369852607 | chr2:34965928-34965929 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs542306280 | chr2:34965971-34965972 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs184443962 | chr2:34965980-34965981 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs13028493 | chr2:34965984-34965985 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs530628168 | chr2:34966010-34966011 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs3108094 | chr2:34966016-34966017 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs189929717 | chr2:34966045-34966046 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs78929720 | chr2:34966046-34966047 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs533022505 | chr2:34966062-34966063 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs546313502 | chr2:34966090-34966091 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs566438785 | chr2:34966101-34966102 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs532963366 | chr2:34966155-34966156 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs34792292 | chr2:34966214-34966215 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs79991355 | chr2:34966215-34966216 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs182568680 | chr2:34966227-34966228 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs185544176 | chr2:34966229-34966230 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs190448556 | chr2:34966259-34966260 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs571199637 | chr2:34966267-34966268 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs180892771 | chr2:34966328-34966329 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs553139958 | chr2:34966343-34966344 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs573181217 | chr2:34966352-34966353 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17393978 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bladder cancer | 21909424 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 19521722 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21364760 | CNVD |
Wilms tumour | 21544195 | CNVD |
Non-small cell lung cancer | 18927303 | CNVD |
Hereditary gingival fibromatosis | 19633868 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21045282 | CNVD |
Prostate cancer | 21965145 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Neurocytoma | 17123091 | CNVD |
Autism | 22495309 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:34961400-34967400 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
2 | chr2:34961600-34966000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr2:34966000-34966600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |